The online version of this article (doi:10.1186/1475-2840-11-115) contains supplementary material, which is available to authorized users.
The authors declare no conflict of interest.
ASB and FA designed the study. BC and BA did the cardiac surgeries. SG and ASB consulted the patients. FA and GA performed the molecular analysis. CD performed and analyzed the CT scans of the study group. DG performed the biochemical analysis. ZY performed the fatty acids analysis. GT and SBG performed the immunohistochemical staining and analysis. FA, SG, UO and ZY analyzed the data. FA drafted the manuscript. All authors contributed to the final version of the manuscript.
Visceral fat deposition and its associated atherogenic complications are mediated by glucocorticoids. Cardiac visceral fat comprises mediastinal adipose tissue (MAT) and epicardial adipose tissue (EAT), and MAT is a potential biomarker of risk for obese patients.
Our objective was to evaluate the role of EAT and MAT 11beta-hydroxysteroid dehydrogenase type 1 (11β-HSD-1) and glucocorticoid receptor (GCR) expression in comparison with subcutaneous adipose tissue (SAT) in the development of coronary atherosclerosis in obese patients with coronary artery disease (CAD), and to assess their correlations with CD68 and fatty acids from these tissues.
Expression of 11β-HSD-1 and GCR was measured by qRT-PCR in EAT, MAT and SAT of thirty-one obese patients undergoing coronary artery bypass grafting due to CAD (obese CAD group) and sixteen obese patients without CAD undergoing heart valve surgery (controls). 11β-HSD-1 and GCR expression in MAT were found to be significantly increased in the obese CAD group compared with controls (p < 0.05). In the obese CAD group, 11β-HSD-1 and GCR mRNA levels were strongly correlated in MAT. Stearidonic acid was significantly increased in EAT and MAT of the obese CAD group and arachidonic acid was significantly expressed in MAT of the obese male CAD group (p < 0.05).
We report for the first time the increased expression of 11β-HSD-1 and GCR in MAT compared with EAT and SAT, and also describe the interrelated effects of stearidonic acid, HOMA-IR, plasma cortisol and GCR mRNA levels, explaining 40.2% of the variance in 11β-HSD-1 mRNA levels in MAT of obese CAD patients. These findings support the hypothesis that MAT contributes locally to the development of coronary atherosclerosis via glucocorticoid action.
Iacobellis G, Ribaudo MC, Assael F, Vecci E, Tiberti C, Zappaterreno A, Di Mario U, Leonetti F: Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab. 2003, 88: 5163-5168. 10.1210/jc.2003-030698. CrossRefPubMed
Sicari R, Sironi AM, Petz R, Frassi F, Chubuchny V, De Marchi D, Positano V, Lombardi M, Picano E, Gastaldelli A: Pericardial rather than epicardial fat is a cardiometabolic risk marker: an MRI vs echo study. J Am Soc Echocardiogr. 2011, 24 (10): 1156-1162. 10.1016/j.echo.2011.06.013. CrossRefPubMed
Konishi M, Sugiyama S, Sato Y, Oshima S, Sugamura K, Nozaki T, Ohba K, Matsubara J, Sumida H, Nagayoshi Y, Sakamoto K, Utsunomiya D, Awai K, Jinnouchi H, Matsuzawa Y, Yamashita Y, Asada Y, Kimura K, Umemura S, Ogawa H: Pericardial fat inflammation correlates with coronary artery disease. Atherosclerosis. 2010, 213: 649-655. 10.1016/j.atherosclerosis.2010.10.007. CrossRefPubMed
Nelson AJ, Worthley MI, Psaltis PJ, Carbone A, Dundon BK, Duncan RF, Piantadosi C, Lau DH, Sanders P, Wittert GA, Worthley SG: Validation of cardiovascular magnetic resonance assessment of pericardial adipose tissue volume. J Cardiovasc Magn Reson. 2009, 5: 11-15.
Rosito GA, Massaro JM, Hoffmann U, Ruberg FL, Mahabadi AA, Vasan RS, O'Donnell CJ, Fox CS: Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation. 2008, 117: 605-613. 10.1161/CIRCULATIONAHA.107.743062. CrossRefPubMed
Lindsay RS, Wake DJ, Nair S, Bunt J, Livingstone DEW, Permana PA, Tataranni PA, Walker BR: Subcutaneous adipose 11β-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians. J Clin Endocrinol Metab. 2003, 88: 2738-2744. 10.1210/jc.2002-030017. CrossRefPubMed
Rask E, Walker BR, Soderberg S, Livingstone DE, Eliasson M, Johnson O, Andrew R, Olsson T: Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11β-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab. 2002, 87: 3330-3336. 10.1210/jc.87.7.3330. PubMed
Silaghi A, Silaghi H, Scridon T, Pais R, Achard V: Glucocorticoid receptors in human epicardial adipose tissue: role of coronary status. J Endocrinol Invest. 2011, 35: 649-654. PubMed
Onat A, Hergenc G, Can G: Prospective validation in identical Turkish cohort of two metabolic syndrome definitions for predicting cardiometabolic risk and selection of most appropriate definition. Anadolu Kardiyol Derg. 2007, 7: 29-34. PubMed
Hirata A, Maeda N, Nakatsuji H, Hiuge-Shimizu A, Okada T, Funahashi T, Shimomura I: Contribution of glucocorticoid-mineralocorticoid receptor pathway onthe obesity related adipocyte dysfunction. Biochem Biophys Res Commun. 2012, 9;419 (2)): 182-187. CrossRef
Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D, Jamieson P, Best R, Brown R, Edwards CR, Seckl JR, Mullins JJ: 11β-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid inducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci USA. 1997, 94: 14924-14929. 10.1073/pnas.94.26.14924. PubMedCentralCrossRefPubMed
Morton NM, Paterson JM, Masuzaki H, Holmes MC, Staels B, Fievet C, Walker BR, Flier JS, Mullins JJ, Seckl JR: Novel adipose tissue mediated resistance to diet-induced visceral obesity in 11β-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes. 2004, 53: 931-938. 10.2337/diabetes.53.4.931. CrossRefPubMed
Gormez S, Demirkan A, Atalar F, Caynak B, Erdim R, Sozer V, Gunay D, Akpinar B, Ozbek U, Buyukdevrim AS: Adipose tissue gene expression of adiponectin, tumor necrosis factor -α and leptin in metabolic syndrome patients with coronary artery disease. Intern Med. 2011, 50 (8): 805-810. 10.2169/internalmedicine.50.4753. CrossRefPubMed
Schlett CL, Ferencik M, Kriegel MF, Bamberg F, Ghoshhajra BB, Joshi SB, Nagurney JT, Fox CS, Truong QA, Hoffmann U: Association of pericardial fat and coronary high-risk lesions as determined by cardiac CT. Atherosclerosis. 2012, 222 (1): 129-134. 10.1016/j.atherosclerosis.2012.02.029. PubMedCentralCrossRefPubMed
Fox CS, Gona P, Hoffmann U, Porter SA, Salton CJ, Massaro JM, Levy D, Larson MG, D'Agostino RB, O'Donnell CJ, Manning WJ: Pericardial fat, intrathoracic fat, and measures of left ventricular structure and function: the Framingham Heart Study. Circulation. 2009, 119 (12): 1586-1591. 10.1161/CIRCULATIONAHA.108.828970. PubMedCentralCrossRefPubMed
Ahmadi N, Nabavi V, Yang E, Hajsadeghi F, Lakis M, Flores F, Zeb I, Bevinal M, Ebrahimi R, Budoff M: Increased epicardial, pericardial, and subcutaneous adipose tissue is associated with the presence and severity of coronary artery calcium. Acad Radiol. 2010, 17 (12): 1518-1524. 10.1016/j.acra.2010.08.017. CrossRefPubMed
Park JS, Ahn SG, Hwang JW, Lim HS, Choi BJ, Choi SY, Yoon MH, Hwang GS, Tahk SJ, Shin JH: Impact of body mass index on the relationship of epicardial adipose tissue to metabolic syndrome and coronary artery disease in an Asian population. Cardiovasc Diabetol. 2010, 9: 29-10.1186/1475-2840-9-29. PubMedCentralCrossRefPubMed
Baker AR, Harte AL, Howell N, Pritlove DC, Ranasinghe AM, da Silva NF, Youssef EM, Khunti K, Davies MJ, Bonser RS, Kumar S, Pagano D, McTernan PG: Epicardial adipose tissue as a source of nuclear factor-κB and c-Jun N-terminal kinase mediated inflammation in patients with coronary artery disease. JCEM. 2009, 94: 261-267. PubMed
Paulsen SK, Pedersen SB, Jørgensen JO, Fisker S, Christiansen JS, Flyvbjerg A, Richelsen B: Growth hormone (GH) substitution in GH-deficient patients inhibits 11beta-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in adipose tissue. J Clin Endocrinol Metab. 2006, 91: 1093-1098. CrossRefPubMed
Vara Prasad SS, Jeya Kumar SS, Kumar PU, Qadri SS, Vajreswari A: Dietary fatty acid composition alters 11β-hydroxysteroid dehydrogenase type 1 gene expression in rat retroperitoneal white adipose tissue. Lipids Health Dis. 2010, 89: 111. CrossRef
- The role of mediastinal adipose tissue 11β-hydroxysteroid d ehydrogenase type 1 and glucocorticoid expression in the development of coronary atherosclerosis in obese patients with ischemic heart disease
Ahmet Sevim Buyukdevrim
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
e.Med Kampagnen-Visual, Mail Icon II